These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3810973)

  • 1. [Cytostatic treatment of metastatic adenocarcinoma and anaplastic carcinoma of unknown primary origin].
    Aabo K; Rørth M; Hansen HH
    Ugeskr Laeger; 1987 Jan; 149(2):80-1. PubMed ID: 3810973
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.
    Taal BG; Veenhof CH; Blijham GH; Neijt JP
    Neth J Med; 1988 Apr; 32(3-4):204-11. PubMed ID: 3283582
    [No Abstract]   [Full Text] [Related]  

  • 3. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The chemotherapy of metastases of unknown origin].
    Shparyk IaV; Bilyns'kyĭ VT
    Lik Sprava; 1996; (1-2):45-52. PubMed ID: 9005104
    [No Abstract]   [Full Text] [Related]  

  • 5. [A successful combination therapy with resection and infusion chemotherapy for a patient with metastases from cancer of unknown origin].
    Nakagawa Y; Todoroki T; Koike N; Kawamoto T
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):423-6. PubMed ID: 12669405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of carcinoma of unknown primary site (CUP), any changes?
    Hansen HH; Daugaard G
    Ann Oncol; 2001 Apr; 12(4):431-2. PubMed ID: 11398871
    [No Abstract]   [Full Text] [Related]  

  • 7. One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-101-S19-105. PubMed ID: 9427278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic carcinoma of unknown origin].
    Fizazi K; Culine S
    Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surprisingly positive effect of palliative CAP chemotherapy of bone-disseminated, undifferentiated carcinoma of unknown primary origin in patient with low performance status according to WHO].
    Swiatoniowski G; Bruzewicz S; Suder E; Warszylewicz-Szymanek M; Kłaniewski T; Prudlak E; Molenda W; Setta M
    Przegl Lek; 2006; 63(3):166-8. PubMed ID: 16969902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The CUP syndrome--malignant disease with unknown primary tumor. Part 4: Therapy and prognosis].
    Jaspersen D
    Fortschr Med; 1992 Nov; 110(31):587-8. PubMed ID: 1478594
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients.
    Alberts AS; Falkson G; Falkson HC; van der Merwe MP
    Med Pediatr Oncol; 1989; 17(3):188-92. PubMed ID: 2747591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of unknown primary site.
    Greco FA; Burris HA; Erland JB; Gray JR; Kalman LA; Schreeder MT; Hainsworth JD
    Cancer; 2000 Dec; 89(12):2655-60. PubMed ID: 11135228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
    Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
    Greco FA; Hainsworth JD
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
    Strickland AH; Karapetis CS; Yip D; Harper PG
    Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic occult primary cancer].
    Aabo K
    Ugeskr Laeger; 1987 Jan; 149(2):76-9. PubMed ID: 3544422
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets.
    Pavlidis N
    Ann Oncol; 2012 Sep; 23 Suppl 10():x282-5. PubMed ID: 22987978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
    Polyzos A; Koulentianos E; Tzianoumis L; Sfikakis P
    J Chemother; 1989 Jul; 1(4 Suppl):1185-6. PubMed ID: 16312826
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of squamous cell carcinoma of unknown primary site with involvement of cervico-mediastinal lymph nodes successfully treated by chemoradiotherapy].
    Watanabe S; Tanaka J; Tsuboi K; Tanaka H; Kagamu H; Yoshizawa H; Suzuki E; Gejyo F
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1493-5. PubMed ID: 17033245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.